부산대학교 도서관

Joaquin Garcia A; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Rediti M; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Venet D; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Majjaj S; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Kammler R; Translational Research Coordination International Breast Cancer Study Group, Division of ETOP IBCSG Partners Foundation, Bern, Switzerland.; Munzone E; European Institute of Oncology, Milan, Italy.; Gianni L; Department of Medical Oncology, Ospedale Infermi, Rimini, AUSL della Romagna, Italy.; Thürlimann B; Kantonsspital St Gallen, St Gallen, Switzerland.; Laáng I; National Institute of Oncology, Budapest, Hungary.; Colleoni M; International Breast Cancer Study Group, Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Loi S; International Breast Cancer Study Group, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Viale G; IEO European Institute of Oncology IRCCS, Milan, Italy.; Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Buisseret L; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Rothé F; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.; Burstein HJ; Medical Oncology, Dana-Farber Cancer Institute, Boston; Harvard Medical School, Boston, USA. Electronic address: hal_burstein@dfci.harvard.edu.; Gnant M; Comprehensive Cancer Center, Medical University of Vienna, Vienna; Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.; Loibl S; Center for Hematology and Oncology Bethanien, Frankfurt; German Breast Group, Neu-Isenburg, Germany.; Cameron D; Edinburgh Cancer Research Centre, University of Edinburgh and NHS Lothian, Edinburgh, UK.; Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Denkert C; Institut für Pathologie, Philipps-Universität Marburg und Universitätsklinikum Marburg, Marburg, Germany.; Poortmans P; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp; University of Antwerp, Faculty of Medicine and Health Sciences, Wilrijk-Antwerp, Belgium.; Weber WP; Department of Surgery, University Hospital Basel, Basel, Switzerland; Faculty of Medicine, University of Basel, Basel, Switzerland.; Thürlimann B; SwissBreastCare, Bethanienspital, Zürich, Switzerland; SONK Foundation, St. Gallen, Switzerland.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Regan MM; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: mregan@jimmy.harvard.edu.; Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.; McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA, USA.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Pusztai L; Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT.; Rugo HS; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Garrett-Mayer E; American Society of Clinical Oncology, Alexandria, VA.; Amiri-Kordestani L; US Food and Drug Administration, Silver Spring, MD.; Basho RK; The Lawrence J. Ellison Institute for Transformative Medicine, Los Angeles, CA.; Best AF; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD.; Boileau JF; Department of Surgery, McGill University, Montreal, Quebec, Canada.; Denkert C; Institute of Pathology, Philipps University Marburg and University Hospital Marburg (UKGM), Marburg, Germany.; Foster JC; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD.; Harbeck N; The Breast Center, Department of Obstetrics and Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.; Jacene HA; Department of Radiology, Brigham and Women's Hospital, Boston, MA.; King TA; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Mason G; The Inflammatory Breast Cancer Research Foundation, Broadway, VA.; O'Sullivan CC; Department of Oncology, Mayo Clinic, Rochester, MN.; Prowell TM; US Food and Drug Administration, Silver Spring, MD.; Women's Malignancies Disease Group, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD.; Richardson AL; Department of Pathology, John Hopkins Medicine, Baltimore, MD.; Sepulveda KA; Department of Radiology, Baylor College of Medicine, Houston, TX.; Smith ML; Research Advocacy Network, Plano, TX.; Tjoe JA; Division of Breast Surgery, Department of Surgery, Novant Health, Greensboro, NC.; Turashvili G; Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA.; Woodward WA; Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Butler LP; The Emmes Corporation, Rockville, MD.; Schwartz EI; Coordinating Center for Clinical Trials, National Cancer Institute, Rockville, MD.; Korde LA; Cancer Therapy and Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Munzone E; Division of Medical Senology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; Regan MM; IBCSG Statistical Center, Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Cinieri S; Department of Medical Oncology, Perrino Hospital, ASL Brindisi, Brindisi, Italy.; Montagna E; Division of Medical Senology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; Orlando L; Department of Medical Oncology, Perrino Hospital, ASL Brindisi, Brindisi, Italy.; Shi R; IBCSG Statistical Center, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Campadelli E; Faenza Hospital 'degli Infermi,' Oncology, Faenza, Italy.; Gianni L; Department of Medical Oncology, Ospedale Infermi, AUSL Della Romagna, Rimini, Italy.; Palleschi M; Department of Oncology, IRCCS, Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy.; Petrelli F; Medical Oncology Unit, ASST Bergamo Ovest, Treviglio, Bergamo, Italy.; Bengala C; Division of Medical Oncology, Department of Medical Oncology, Department of Oncology, Azienda USL Toscana, Misericordia Hospital, Grosseto, Italy.; Generali D; Women's Cancer Center, Azienda Socio-Sanitaria Territoriale di Cremona and University of Trieste, Cremona, Italy.; Collovà E; Medical Oncology Unit, ASST Ovest Milanese Legnano, Milan, Italy.; Puglisi F; Department of Medical Oncology, CRO di Aviano, National Cancer Institute, IRCCS, Aviano, Italy.; Department of Medicine, University of Udine, Udine, Italy.; Cretella E; Department of Medical Oncology, Azienda Sanitaria Dell'Alto Adige, Bolzano, Italy.; Zamagni C; IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.; Chini C; Department of Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.; Ruepp B; ETOP IBCSG Partners Foundation, Bern, Switzerland.; Loi S; ETOP IBCSG Partners Foundation, Bern, Switzerland.; Peter MacCallum Cancer Centre, Division of Cancer Research, The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Colleoni M; Division of Medical Senology, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; ETOP IBCSG Partners Foundation, Bern, Switzerland.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Garrido-Castro AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Regan MM; Harvard Medical School, Boston, MA, USA.; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Niman SM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Nakhlis F; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Remolano C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rosenbluth JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Block C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Warren LE; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bellon JR; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Yeh E; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Harrison BT; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Troll E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Overmoyer B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Filipa_Lynce@dfci.harvard.edu.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. Filipa_Lynce@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Filipa_Lynce@dfci.harvard.edu.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Pagani O; Interdisciplinary Cancer Service Hospital Riviera-Chablais Rennaz, Vaud, Switzerland.; Geneva University Hospitals, Lugano University and Swiss Group for Clinical Cancer Research (SAKK), Vaud, Switzerland.; Walley BA; University of Calgary and Canadian Cancer Trials Group, Calgary, AB, Canada.; Fleming GF; The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL.; Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, and International Breast Cancer Study Group, Milan, Italy.; Láng I; Clinexpert-research, Budapest, Hungary (prior affiliation).; National Institute of Oncology and International Breast Cancer Study Group, Budapest, Hungary.; Gomez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; International Breast Cancer Study Group, Lima, Peru.; Tondini C; Osp. Papa Giovanni XXIII and International Breast Cancer Study Group, Bergamo, Italy.; Burstein HJ; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School and Alliance for Clinical Trials in Oncology, Boston, MA.; Goetz MP; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, MN.; Ciruelos EM; Medical Oncology Department, University Hospital 12 de Octubre and SOLTI Breast Cancer Research Cooperative Group, Madrid, Spain.; Stearns V; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and ECOG-ACRIN, Baltimore, MD.; Bonnefoi HR; Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U1312, and European Organisation for Research and Treatment of Cancer (EORTC), Bordeaux, France.; Martino S; The Angeles Clinic and Research Institute and SWOG, Santa Monica, CA.; Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center and NRG Oncology, Pittsburgh, PA.; Chini C; Deaprment of Medical Oncology, Ospedale di Circolo e Fondazione, Lombardy, Italy.; Puglisi F; Department of Medicine (DAME), University of Udine, Italy and Department of Medical Oncology, IRCCS, Centro di Riferimento Oncologico CRO di Aviano, Aviano, Italy.; Spazzapan S; Department of Medical Oncology, IRCCS, Centro di Riferimento Oncologico CRO di Aviano, Aviano, Italy.; Ruhstaller T; University of Basel, Swiss Group for Clinical Cancer Research (SAKK) and International Breast Cancer Study Group, Basel, Switzerland.; Winer EP; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School and Alliance for Clinical Trials in Oncology, Boston, MA.; Yale Cancer Center, Yale School of Medicine; Smilow Cancer Hospital, New Haven, CT (prior affiliation).; Ruepp B; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.; Loi S; International Breast Cancer Study Group and Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Victoria, Australia.; Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.; Gelber RD; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, MA.; Goldhirsch A; European Institute of Oncology, IRCCS, International Breast Cancer Study Group, Milan, Italy.; Deceased.; Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Francis PA; Peter MacCallum Cancer Center, St Vincent's Hospital, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Australia; International Breast Cancer Study Group, Melbourne, Australia.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Francis PA; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Center, St Vincent's Hospital, University of Melbourne, Melbourne, Australia.; Breast Cancer Trials Australia & New Zealand, University of Newcastle, Callaghan, Newcastle, Australia.; International Breast Cancer Study Group, Bern, Switzerland.; Fleming GF; The University of Chicago Medical Center and Alliance for Clinical Trials in Oncology, Chicago, IL.; Láng I; Clinexpert-Research, Budapest, Hungary.; National Institute of Oncology and International Breast Cancer Study Group, Budapest, Hungary.; Ciruelos EM; Medical Oncology Department, University Hospital and SOLTI Breast Cancer Research Cooperative Group, Madrid, Spain.; Bonnefoi HR; Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U1312, and European Organisation for Research and Treatment of Cancer (EORTC), Bordeaux, France.; Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, and SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Bernardo A; Medical Oncology Unit, ICS Maugeri-IRCCS, Pavia, Italy.; Climent MA; Instituto Valenciano de Oncologia, Valencia and SOLTI Breast Cancer Research Cooperative Group, Barcelona, Spain.; Martino S; The Angeles Clinic and Research Institute and SWOG, Santa Monica, CA.; Bermejo B; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Incliva, Barcelona, Spain.; Medicine Department Universidad de Valencia, Valencia and SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.; Burstein HJ; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School and Alliance for Clinical Trials in Oncology, Boston, MA.; Davidson NE; Fred Hutchinson Cancer Center, University of Washington and ECOG-ACRIN, Seattle, WA.; Geyer CE Jr; University of Pittsburgh Medical Center Hillman Cancer Center and NRG Oncology, Pittsburgh, PA.; Walley BA; University of Calgary and Canadian Cancer Trials Group, Calgary, Alberta, Canada.; Ingle JN; Mayo Clinic and Alliance for Clinical Trials in Oncology, Rochester, MN.; Coleman RE; Weston Park Hospital, Sheffield, United Kingdom.; NCRI Breast Cancer Clinical Studies Group, London, United Kingdom.; ICR-CTSU, London, United Kingdom.; Müller B; Chilean Cooperative Group for Oncological Research (GOCCHI), Santiago, Chile.; Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.; Loibl S; German Breast Group, Neu-Isenburg, Germany.; Goethe University of Frankfurt, Frankfurt, Germany.; Winer EP; Susan F. Smith Center for Women's Cancers, Dana-Farber Cancer Institute, Harvard Medical School and Alliance for Clinical Trials in Oncology, Boston, MA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT.; Smilow Cancer Hospital, New Haven, CT.; Ruepp B; International Breast Cancer Study Group Coordinating Center, Bern, Switzerland.; Loi S; International Breast Cancer Study Group and Peter MacCallum Cancer Center, University of Melbourne, Melbourne, Victoria, Australia.; Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS and International Breast Cancer Study Group, Milan, Italy.; Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.; Gelber RD; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health, Frontier Science Foundation, Boston, MA.; Goldhirsch A; IEO, European Institute of Oncology, IRCCS and International Breast Cancer Study Group, Milan, Italy.; Regan MM; International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Franzoi MA; INSERM Unit 981 e Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.; Trapani D; Department of Medical Oncology, Dana-Farber Cancer Center, Boston, USA; Harvard Medical School, Boston, USA.; Jezdic S; Scientific and Medical Division, European Society for Medical Oncology, Lugano, Switzerland.; Regan MM; Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.; Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy; New Drugs Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.; Andre F; INSERM Unit 981 e Molecular Predictors and New Targets in Oncology, PRISM Center for Precision Medicine, Gustave Roussy, Villejuif, France.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Warren LEG; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Niman SM; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Remolano MC; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Landry JM; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Nakhlis F; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Bellon JR; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Aizer AA; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Regan MM; Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Overmoyer BA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Lynce F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE